← brief for 2026-10-16 · Slowing decline

Closing the gap: disparities in access to and implementation of guideline-directed medical therapy for CKM syndrome

Paper No results yet Not peer reviewed

Key takeaways

This article discusses why many people do not get the standard drugs for heart and kidney disease. It points to barriers like cost and access in different regions. The piece is a commentary and does not report new study results.

Source

Paper · Nature Reviews Nephrology · 2026-10-16
https://www.nature.com/articles/s41581-026-01136-3